Metabolic polymorphisms and biomarkers of effect in the biomonitoring of occupational exposure to low-levels of benzene: State of the art

Toxicology Letters

Volumn 231, Issue 2, 2014, Pages 194-204

  De Palma, G ^a   Manno, M ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Benzene; Biological monitoring; Genetic polymorphism; Genotoxicity

Indexed keywords

BENZENE; BIOLOGICAL MARKER; CYTOCHROME P450 2E1; CYTOSINE; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MICRORNA; NITRATE REDUCTASE [NAD(P)H]; ACETYLCYSTEINE; GLUTATHIONE TRANSFERASE; NQO1 PROTEIN, HUMAN; POLLUTANT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); S-PHENYL-N-ACETYLCYSTEINE; TRANSCRIPTOME;

ARTICLE; BIOLOGICAL MONITORING; BIOTRANSFORMATION; BLOOD TOXICITY; CARCINOGENICITY; CYTOSINE METHYLATION; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; HUMAN; METABOLIC POLYMORPHISM; METHYLATION; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; ANALOGS AND DERIVATIVES; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; POLLUTANT; PROCEDURES; TOXICITY; URINE;

ACETYLCYSTEINE; BENZENE; BIOLOGICAL MARKERS; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; TRANSCRIPTOME;

EID: 84921328298     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.10.007     Document Type: Article

References (152)

1. Agency for Toxic Substances and Disease Registry (ATSDR) [Internet], 2007. Toxicological Profile for Benzene (Update). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service. Available from: . http://www.atsdr.cdc.gov/toxprofiles/tp3.html.
2. Andreoli R., Protano C., Manini P., De Palma G., Goldoni M., Petyx M., Rondinone B.M., Vitali M., Mutti A. Association between environmental exposure to benzene and oxidative damage to nucleic acids in children. Med. Lav. 2012, 103:324-337.
3. Angelini S., Kumar R., Bermejo J.L., Maffei F., Barbieri A., Graziosi F., et al. Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and S-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes. Mutat. Res. 2011, 719:7-13.
4. Angelini S., Maffei F., Bermejo J.L., Ravegnini G., L'insalata D., Cantelli-Forti G., Violante F.S., Hrelia P. Environmental exposure to benzene: micronucleus formation and polymorphisms in DNA-repair genes: a pilot study. Mutat. Res. 2012, 743:99-104.
5. Avogbe P.H., Ayi-Fanou L., Autrup H., Loft S., Fayomi B., Sanni A., Vinzents P., Møller P. Ultrafine particulate matter and high-level benzene urban air pollution in relation to oxidative DNA damage. Carcinogenesis 2005, 26:613-620.
6. Bai W., Chen Y., Yang J., Niu P., Tian L., Gao A. Aberrant miRNA profiles associated with chronic benzene poisoning. Exp. Mol. Pathol. 2014, 96:426-430.
7. Basso E., Cevoli C., Papacchini M., Tranfo G., Mansi A., Testa A. Cytogenetic biomonitoring on a group of petroleum refinery workers. Environ. Mol. Mutagen. 2011, 52:440-447.
8. Bergamaschi E., Brustolin A., De Palma G., Manini P., Mozzoni P., Andreoli R., Cavazzini S., Mutti A. Biomarkers of dose and susceptibility in cyclists exposed to monoaromatic hydrocarbons. Toxicol. Lett. 1999, 108:241-247.
9. Bolufer P., Collado M., Barragan E., Calasanz M.J., Colomer D., Tormo M., González M., Brunet S., Batlle M., Cervera J., Sanz M.A. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Br. J. Haematol. 2007, 136:590-596.
10. Bollati V., Baccarelli A., Hou L., Bonzini M., Fustinoni S., Cavallo D., Byun H.M., Jiang J., Marinelli B., Pesatori A.C., Bertazzi P.A., Yang A.S. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007, 67:876-880.
11. Bonassi S., El-Zein R., Bolognesi C., Fenech M. Mcronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis 2011, 26:93-100.
12. Bonassi S., Norppa H., Ceppi M., Strömberg U., Vermeulen R., Znaor A., Cebulska-Wasilewska A., Fabianova E., Fucic A., Gundy S., Hansteen I.L., Knudsen L.E., Lazutka J., Rossner P., Sram R.J., Boffetta P. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 2008, 29:1178-1183.
13. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007, 28:625-631.
14. Boogaard P.J., van Sittert N.J. Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environ. Health Perspect. 1996, 104(Suppl. 6):1151-1157.
15. Buthbumrung N., Mahidol C., Navasumrit P., Promvijit J., Hunsonti P., Autrup H., Ruchirawat M. Oxidative DNA damage and influence of genetic polymorphisms among urban and rural schoolchildren exposed to benzene. Chem. Biol. Interact. 2008, 172:185-194.
16. Byun H.M., Panni T., Motta V., Hou L., Nordio F., Apostoli P., Bertazzi P.A., Baccarelli A.A. Effects of airborne pollutants on mitochondrial DNA methylation. Part. Fibre Toxicol. 2013, 10:18.
17. Carere A., Andreoli C., Galati R., Leopardi P., Marcon F., Rosati M.V., Rossi S., Tomei F., Verdina A., Zijno A., Crebelli R. Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen. Mutat. Res. 2002, 518:215-224.
18. Carrieri M., Bartolucci G.B., Scapellato M.L., Spatari G., Sapienza D., Soleo L., et al. Influence of glutathione S-transferases polymorphisms on biological monitoring of exposure to low doses of benzene. Toxicol. Lett. 2012, 213:63-68.
19. Carugno M., Pesatori A.C., Dioni L., Hoxha M., Bollati V., Albetti B., Byun H.M., Bonzini M., Fustinoni S., Cocco P., Satta G., Zucca M., Merlo D.F., Cipolla M., Bertazzi P.A., Baccarelli A. Increased mitochondrial DNA copy number in occupations associated with low-dose benzene exposure. Environ. Health Perspect. 2012, 120:210-215.
20. Chanvaivit S., Navasumrit P., Hunsonti P., Autrup H., Ruchirawat M. Exposure assessment of benzene in Thai workers: DNA-repair capacity and influence of genetic polymorphisms. Mutat. Res. 2007, 626:79-87.
21. Chen Y., Li G., Yin S., Xu J., Ji Z., Xiu X., Liu L., Ma D. Genetic polymorphisms involved in toxicant-metabolizing enzymes and the risk of chronic benzene poisoning in Chinese occupationally exposed populations. Xenobiotica 2007, 37:103-112.
22. Collins J.J., Conner P., Friedlander B.R., Easterday P.A., Nair R.S., Braun J. A study of the hematologic effects of chronic low-level exposure to benzene. J. Occup. Med. 1991, 33:619-626.
23. Collins J.J., Ireland B.K., Easterday P.A., Nair R.S., Braun J. Evaluation of lymphopenia among workers with low-level benzene exposure and the utility of routine data collection. J. Occup. Environ. Med. 1997, 39:232-237.
24. Dahabreh I.J., Giannouli S., Gota V., Voulgarelis M. GSTT1 and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Int. J. Cancer 2010, 126:1716-1723.
25. De Smet C., De Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7149-7153.
26. Deneberg S., Grövdal M., Karimi M., Jansson M., Nahi H., Corbacioglu A., Gaidzik V., Döhner K., Paul C., Ekström T.J., Hellström-Lindberg E., Lehmann S. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia 2010, 24:932-941.
27. Dinkova-Kostova A.T., Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1): a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 2010, 501:116-123.
28. Dor F., Dab W., Empereur-Bissonnet P., Zmirou D. Validity of biomarkers in environmental health studies: the case of PAHs and benzene. Crit. Rev. Toxicol. 1999, 29:129-168.
29. EC, 1991. European Commission, Employment, Social Affairs and Inclusion. Recommendation from the Scientific Committee on Occupational Exposure Limits for benzene SCOEL/SUM/140 December 1991.
30. EPA, 2003. Environmental Protection Agency Washington AC:45. Benzene (CASRN 71-43-2). Available from: . http://www.epa.gov/ncea/iris/subst/0276.htm.
31. Forni A. Benzene-induced chromosome aberrations: a follow-up study. Environ Health Perspect. 1996, 104(Suppl. 6):1309-1312.
32. Forrest M.S., Lan Q., Hubbard A.E., Zhang L., Vermeulen R., Zhao X., Li G., Wu Y.Y., Shen M., Yin S., Chanock S.J., Rothman N., Smith M.T. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ. Health Perspect. 2005, 113:801-807.
33. Fracasso M.E., Doria D., Bartolucci G.B., Carrieri M., Lovreglio P., Ballini A., et al. Low air levels of benzene: correlation between biomarkers of exposure and genotoxic effects. Toxicol. Lett. 2010, 192:22-28.
34. Fukami T., Katoh M., Yamazaki H., Yokoi T., Nakajima M. Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene styrene, and toluene. Chem. Res. Toxicol. 2008, 21:720-725.
35. Fustinoni S., Consonni D., Campo L., Buratti M., Colombi A., Pesatori A.C., et al. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers influence of cigarette smoking, and genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2237-2244.
36. Fustinoni S., Rossella F., Polledri E., Bollati V., Campo L., Byun H.M., Agnello L., Consonni D., Pesatori A.C., Baccarelli A., Bertazzi P.A. Global DNA methylation and low-level exposure to benzene. Med. Lav. 2012, 103:84-95.
37. Garte S., Taioli E., Popov T., Bolognesi C., Farmer P., Merlo F. Genetic susceptibility to benzene toxicity in humans. J. Toxicol. Environ. Health A 2008, 71:1482-1489.
38. Gaskell M., McLuckie K.I., Farmer P.B. Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. Chem. Biol. Interact. 2005, 153-154:267-270.
39. Glass D.C., Gray C.N., Jolley D.J., Gibbons C., Sim M.R., Fritschi L., et al. Leukemia risk associated with low-level benzene exposure. Epidemiology 2003, 14:569-577.
40. Glass D.C., Schnatter A.R., Tang G., Irons R.D., Rushton L. Risk of myeloproliferative disease and chronic myeloid leukaemia following exposure to low-level benzene in a nested case-control study of petroleum workers. Occup. Environ. Med. 2014, 71:266-274.
41. Greim H., Kaden D.A., Larson R.A., Palermo C.M., Rice J.M., Ross D., Snyder R. The bone marrow niche, stem cells, and leukemia: impact of drugs chemicals, and the environment. Ann. N. Y. Acad. Sci. 2014, 1310:7-31.
42. Guha N., Chang J.S., Chokkalingam A.P., Wiemels J.L., Smith M.T., Buffler P.A. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am. J. Epidemiol. 2008, 168:1221-1232.
43. Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 1994, 3:421-428.
44. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 1991, 110:559-565.
45. Hedges D.J., Deininger P.L. Inviting instability: Transposable elements, double-strand breaks, and the maintenance of genome integrity. Mutation Res. 2007, 616:46-59.
46. Hosagrahara V.P., Rettie A.E., Hassett C., Omiecinski C.J. Functional analysis of human microsomal epoxide hydrolase genetic variants. Chem. Biol. Interact. 2004, 150:149-159.
47. Hou L., Zhang X., Gawron A.J., Liu J. Surrogate tissue telomere length and cancer risk: shorter or longer?. Cancer Lett. 2012, 319:130-135.
48. Hoxha M., Dioni L., Bonzini M., Pesatori A.C., Fustinoni S., Cavallo D., Carugno M., Albetti B., Marinelli B., Schwartz J., Bertazzi P.A., Baccarelli A. Association between leukocyte telomere shortening and exposure to traffic pollution: a cross-sectional study on traffic officers and indoor office workers. Environ. Health 2009, 8:41.
49. Hsieh L.L., Liou S.H., Chiu L.L., Chen Y.H. Glutathione S-transferase (GST) M1 and GST T1 genotypes and hematopoietic effects of benzene exposure. Arch. Toxicol. 1999, 73:80-82.
50. Hug N., Lingner J. Telomere length homeostasis. Chromosoma 2006, 115:413-425.
51. Stubbins M.J., Wolf R. Additional polymorphisms and cancer. Metabolic Polymorphisms and Susceptibility to Cancer 1999, 278-280. IARC Sci Publ N. 148, IARC, Lyon, France. P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, P. Boffetta (Eds.).
52. Infante P.F., Rinsky R.A., Wagoner J.K., Young R.J. Leukaemia in benzene workers. Lancet 1977, 2:76-78.
53. IARC (International Agency for Research on Cancer), 2012. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Benzene. In: Chemical agents and related occupations. 100 F, Lyon, France, World Health Organisation, pp 1-46.
54. Irons R.D., Chen Y., Wang X., Ryder J., Kerzic P.J. Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease. Genes Chromosomes Cancer 2013, 52:887-894.
55. Ji Z., Weldon R.H., Marchetti F., Chen H., Li G., Xing C., Kurtovich E., Young S., Schmid T.E., Waidyanatha S., Rappaport S., Zhang L., Eskenazi B. Comparison of aneuploidies of chromosomes 21 X, and Y in the blood lymphocytes and sperm of workers exposed to benzene. Environ. Mol. Mutagen. 2012, 53:218-226.
56. Kim R.B., O'Shea D. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin. Pharmacol. Ther. 1995, 57:645-655.
57. Kim S., Lan Q., Waidyanatha S., Chanock S., Johnson B.A., Vermeulen R., et al. Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet. Genomics 2007, 17:789-801.
58. Kim S., Vermeulen R., Waidyanatha S., Johnson B.A., Lan Q., Smith M.T., et al. Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2246-2252.
59. Kim S., Vermeulen R., Waidyanatha S., Johnson B.A., Lan Q., Rothman N., Smith M.T., Zhang L., Li G., Shen M., Yin S., Rappaport S.M. Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis 2006, 27:772-781.
60. Kim S.Y., Choi J.K., Cho Y.H., Chung E.J., Paek D., Chung H.W. Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 2004, 14:453-463.
61. Kim Y.J., Choi J.Y., Paek D., Chung H.W. Association of the NQO1, MPO, and XRCC1 polymorphisms and chromosome damage among workers at a petroleum refinery. J. Toxicol. Environ. Health A 2008, 71:333-341.
62. Kirkeleit J., Riise T., Gjertsen B.T., Moen B.E., Bråtveit M., Bruserund O. Effects of benzene on human hematopoiesis. Open Hematol. J. 2008, 2:87-102.
63. Lan Q., Zhang L., Li G., Vermeulen R., Weinberg R.S., Dosemeci M., et al. Hematotoxicity in workers exposed to low levels of benzene. Science 2004, 306:1774-1776.
64. Lan Q., Vermeulen R., Zhang L.P., Li G.L., Rosenberg P.S., Alter B.P., Shen M., Rappaport S.M., Weinberg R.S., Chanock S., Waidyanatha S., Rabkin C., Hayes R.B., Linet M., Kim S., Yin S., Rothman N., Smith M.T. Author reply on: benzene exposure and hematotoxicity (Lamm, S.H., Grünwald, H.W.). Science 2006, 312:998-999.
65. Lan Q., Zhang L., Shen M., Jo W.J., Vermeulen R., Li G., Vulpe C., Lim S., Ren X., Rappaport S.M., Berndt S.I., Yeager M., Yuenger J., Hayes R.B., Linet M., Yin S., Chanock S., Smith M.T., Rothman N. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis 2009, 30:50-58.
66. Larson R.A., Wang Y., Banerjee M., Wiemels J., Hartford C., Le Beau M.M., Smith M.T. Prevalence of the inactivating 609C->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999, 94:803-807.
67. Lee H.C., Wei Y.H. Mitochondrial role in life and death of the cell. J. Biomed. Sci. 2000, 7:2-15.
68. Leopardi P., Zijno A., Marcon F., Conti L., Carere A., Verdina A., Galati R., Tomei F., Baccolo T.P., Crebelli R. Analysis of micronuclei in peripheral blood lymphocytes of traffic wardens: effects of exposure metabolic genotypes, and inhibition of excision repair in vitro by ARA-C. Environ. Mol. Mutagen. 2003, 41:126-130.
69. Lin L.C., Chen W.J., Chiung Y.M., Shih T.S., Liao P.C. Association between GST genetic polymorphism and dose-related production of urinary benzene metabolite markers trans, trans-muconic acid and S-phenylmercapturic acid. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1460-1469.
70. Lin S., Vermeulen R., Waidyanatha S., Lan Q., Rothman N., Smith T., Zhang L., Shen M., Li G., Yin S., Kim S., Rappaport M. Albumin adducts of electrophilic benzene metabolites in benzene-exposed and control workers. Environ. Health Perspect. 2007, 115:28-34.
71. Lindsey R.H., Bender R.P., Osheroff N. Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chem. Biol. Interact. 2005, 153-154:197-205.
72. Liu L., Zhang Q., Feng J., Deng L., Zeng N., Yang A., Zhang W. The study of DNA oxidative damage in benzene-exposed workers. Mutat. Res. 1996, 370:145-150.
73. Maffei F., Hrelia P., Angelini S., Carbone F., Cantelli Forti G., Barbieri A., et al. Effects of environmental benzene: micronucleus frequencies and haematological values in traffic police working in an urban area. Mutat. Res. 2005, 583:1-11.
74. Manini P., De Palma G., Andreoli R., Mozzoni P., Poli D., Goldoni M., et al. Occupational exposure to low levels of benzene: Biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes. Toxicol. Lett. 2010, 193:229-235.
75. Manini P., De Palma G., Andreoli R., Poli D., Mozzoni P., Folesani G., et al. Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers. Toxicol. Lett. 2006, 167:142-151.
76. Manno M., Viau C., Cocker J., Colosio C., Lowry L., Mutti A., Nordberg M., Wang S. Biomonitoring for occupational health risk assessment (BOHRA). Toxicol. Lett. 2010, 192:3-16.
77. Mansi A., Bruni R., Capone P., Paci E., Pigini D., Simeoni C., et al. Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary t,t-MA/SPMA ratio. Toxicol. Lett. 2012, 213:57-62.
78. Marchetti F., Eskenazi B., Weldon R.H., Li G., Zhang L., Rappaport S.M., Schmid T.E., Xing C., Kurtovich E., Wyrobek A.J. Occupational exposure to benzene and chromosomal structural aberrations in the sperm of Chinese men. Environ. Health Perspect. 2012, 120:229-234.
79. Mattioli S., Zanardi F., Baldasseroni A., Schaafsma F., Cooke R.M., Mancini G., Fierro M., Santangelo C., Farioli A., Fucksia S., Curti S., Violante F.S., Verbeek J. Search strings for the study of putative occupational determinants of disease. Occup. Environ. Med. 2010, 67:436-443.
80. McHale C.M., Zhang L., Lan Q., Li G., Hubbard A.E., Forrest M.S., Vermeulen R., Chen J., Shen M., Rappaport S.M., Yin S., Smith M.T., Rothman N. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. Genomics 2009, 93:343-349.
81. McHale C.M., Zhang L., Lan Q., Vermeulen R., Li G., Hubbard A.E., et al. Global gene expression profiling of a population exposed to a range of benzene levels. Environ. Health Perspect. 2011, 119:628-634.
82. Melki J.R., Clark S.J. DNA methylation changes in leukaemia. Semin. Cancer Biol. 2002, 12:347-357.
83. Monks T.J., Butterworth M., Lau S.S. The fate of benzene-oxide. Chem. Biol. Interact. 2010, 184:201-206.
84. Morgan G.J., Alvares C.L. Benzene and the hemopoietic stem cell. Chem. Biol. Interact. 2005, 153-154:217-222.
85. Naoe T., Takeyama K., Yokozawa T., Kiyoi H., Seto M., Uike N., Ino T., Utsunomiya A., Maruta A., Jin-nai I., Kamada N., Kubota Y., Nakamura H., Shimazaki C., Horiike S., Kodera Y., Saito H., Ueda R., Wiemels J., Ohno R. Analysis of genetic polymorphism in NQO1 GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin. Cancer Res. 2000, 6:4091-4095.
86. Natelson E.A. Benzene-induced acute myeloid leukemia: a clinician's perspective. Am. J. Hematol. 2007, 82:826-830.
87. Norppa H., Bonassi S., Hansteen I.L., Hagmar L., Strömberg U., Rössner P., Boffetta P., Lindholm C., Gundy S., Lazutka J., Cebulska-Wasilewska A., Fabiánová E., Srám R.J., Knudsen L.E., Barale R., Fucic A. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res. 2006, 600:37-45.
88. Omer A., Yadav N.K., Singh P., Singh R.K. Hematological malignancies: role of miRNAs and their in silico aspects. Expert Rev. Anticancer Ther. 2013, 13:1121-1133.
89. Omiecinski C.J., Hassett C., Hosagrahara V. Epoxide hydrolase-polymorphism and role in toxicology. Toxicol. Lett. 2000, 112-113:365-370.
90. Orphanides G., Reinberg D. A unified theory of gene expression. Cell 2002, 108:439-451.
91. OSHA (Occupational Safety and Health Administration), 1987. Occupational Safety and Health Standards Regulations-29CFR, Standard No. 1910.1028.
92. Passegué E., Weisman I.L. Leukemic stem cells: where do they come from?. Stem Cell Rev. 2005, 1:181-188.
93. Paterni L., Teodori S., Dotta F. Benzene hemopathy: clinical contribution (anerythremic erythromyelopathy) and general concepts. Policlinico Prat. 1954, 61:905-913.
94. Pendleton M., Lindsey R.H., Felix C.A., Grimwade D., Osheroff N. Topoisomerase II and leukemia. Ann. N. Y. Acad. Sci. 2014, 1310:98-110.
95. Pesatori A.C., Garte S., Popov T., Georgieva T., Panev T., Bonzini M., et al. Early effects of low benzene exposure on blood cell counts in Bulgarian petrochemical workers. Med. Lav. 2009, 100:83-90.
96. Piccoli P., Carrieri M., Padovano L., Di Mare M., Bartolucci G.B., Fracasso M.E., et al. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene. Toxicol. Lett. 2010, 192:29-33.
97. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 1996, 271:14412-14420.
98. Pitarque M., Vaglenov A., Nosko M., Pavlova S., Petkova V., Hirvonen A., Creus A., Norppa H., Marcos R. Sister chromatid exchanges and micronuclei in peripheral lymphocytes of shoe factory workers exposed to solvents. Environ. Health Perspect. 2002, 110:399-404.
99. Powley M.W., Carlson G.P. Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes. J. Biochem. Mol. Toxicol. 2000, 14:303-309.
100. Qu Q., Shore R., Li G., Jin X., Chen L.C., Cohen B., Melikian A.A., Eastmond D., Rappaport S.M., Yin S., Li H., Waidyanatha S., Li Y., Mu R., Zhang X., Li K. Hematological changes among Chinese workers with a broad range of benzene exposures. Am. J. Ind. Med. 2002, 42:275-285.
101. Qu Q., Shore R., Li G., Jin X., Chen L.C., Cohen B., Melikian A.A., Eastmond D., Rappaport S., Li H., Rupa D., Waidyanatha S., Yin S., Yan H., Meng M., Winnik W., Kwok E.S., Li Y., Mu R., Xu B., Zhang X., Li K. Validation and evaluation of biomarkers in workers exposed to benzene in China. Res. Rep. Health Eff. Inst. 2003, 115:1-72. Discussion 73-87.
102. Qu Q., Shore R., Li G., Su L., Jin X., Melikian A.A., Roy N., Chen L.C., Wirgin I., Cohen B., Yin S., Li Y., Mu R. Biomarkers of benzene: urinary metabolites in relation to individual genotype and personal exposure. Chem. Biol. Interact. 2005, 153-154:85-95.
103. Rappaport S.M., Yeowell-O'Connell K., Smith M.T., Dosemeci M., Hayes R.B., Zhang L., Li G., Yin S., Rothman N. Non-linear production of benzene oxide-albumin adducts with human exposure to benzene. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 778:367-374.
104. Rappaport S.M., Waidyanatha S., Yeowell-O'Connell K., Rothman N., Smith M.T., Zhang L., Qu Q., Shore R., Li G., Yin S. Protein adducts as biomarkers of human benzene metabolism. Chem. Biol. Interact 2005, 153-154:103-109.
105. Rappaport S.M., Kim S., Lan Q., Vermeulen R., Waidyanatha S., Zhang L., et al. Evidence that humans metabolize benzene via two pathways. Environ. Health Perspect. 2009, 117:946-952.
106. Rappaport S.M., Kim S., Lan Q., Li G., Vermeulen R., Waidyanatha S., Zhang L., Yin S., Smith M.T., Rothman N. Human benzene metabolism following occupational and environmental exposures. Chem. Biol. Interact. 2010, 184:189-195.
107. Rekhadevi P.V., Mahboob M., Rahman M.F., Grover P. Determination of genetic damage and urinary metabolites in fuel filling station attendants. Environ. Mol. Mutagen. 2011, 52:310-318.
108. Rekhadevi P.V., Rahman M.F., Mahboob M., Grover P. Genotoxicity in filling station attendants exposed to petroleum hydrocarbons. Ann. Occup. Hyg. 2010, 54:944-954.
109. Rinsky R.A., Hornung R.W., Silver S.R., Tseng C.Y. Benzene exposure and hematopoietic mortality: A long-term epidemiologic risk assessment. Am. J. Ind. Med. 2002, 42:474-480.
110. Ross D. The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J. Toxicol. Environ. Health A 2000, 61:357-372.
111. Ross D., Zhou H., Siegel D. Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function. Chem. Biol. Interact. 2011, 192:145-149.
112. Rossi A.M., Hansteen I.L., Skjelbred C.F., Ballardin M., Maggini V., Murgia E., Tomei A., Viarengo P., Knudsen L.E., Barale R., Norppa H., Bonassi S. Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. Environ. Health Perspect. 2009, 117:203-208.
113. Rothman N., Smith M.T., Hayes R.B., Traver R.D., Hoener B., Campleman S., et al. Benzene poisoning a risk factor for hematological malignancy, is associated with the NQO1 609C->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 1997, 57:2839-2842.
114. Rushton L., Brown T.P., Cherrie J., Fortunato L., Van Tongeren M., Hutchings S.J. How much does benzene contribute to the overall burden of cancer due to occupation?. Chem. Biol. Interact 2010, 184:290-292.
115. Rushton L., Schnatter A.R., Tang G., Glass D.C. Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers. Br. J. Cancer 2014, 110:783-787.
116. Sacca J.D. Myelogenous leukemia resulting from benzol poisoning. N. Y. State J. Med. 1948, 48:1619.
117. Schnatter A.R., Glass D.C., Tang G., Irons R.D., Rushton L. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J. Natl. Cancer Inst. 2012, 104:1724-1737.
118. Schnatter R.A., Kerzic P.J., Zhou Y., Chen M., Nicolich M.J., Lavelle K., Armstrong T.W., Bird M.G., Lin L., Fu H., Irons R.D. Peripheral blood effects in benzene-exposed workers. Chem. Biol. Interact. 2010, 184:174-181.
119. Seow W.J., Pesatori A.C., Dimont E., Farmer P.B., Albetti B., Ettinger A.S., Bollati V., Bolognesi C., Roggieri P., Panev T.I., Georgieva T., Merlo D.F., Bertazzi P.A., Baccarelli A.A. Urinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression models. PLoS One 2012, 7:e50471.
120. Siegel D., McGuinness S.M., Winski S.L., Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 1999, 9:113-121.
121. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 1996, 104(Suppl. 6):1219-1225.
122. Smith M.T., Vermeulen R., Li G., Zhang L., Lan Q., Hubbard A.E., Forrest M.S., McHale C., Zhao X., Gunn L., Shen M., Rappaport S.M., Yin S., Chanock S., Rothman N. Use of 'Omic' technologies to study humans exposed to benzene. Chem. Biol. Interact. 2005, 153-154:123-127.
123. Smith M.T., Wang Y., Skibola C.F., Slater D.J., Lo Nigro L., Nowell P.C., Lange B.J., Felix C.A. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002, 100:4590-4593.
124. Smith M.T., Zhang L., McHale C.M., Skibola C.F., Rappaport S.M. Benzene: the exposome and future investigations of leukemia etiology. Chem. Biol. Interact. 2011, 192:155-159.
125. Snyder R. The bone marrow niche, stem cells, and leukemia: impact of drugs chemicals, and the environment. Ann. N. Y. Acad. Sci. 2014, 1310:1-6.
126. Snyder R. Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab. Rev. 2004, 36:531-547.
127. Snyder R. Benzene's toxicity: a consolidated short review of human and animal studies by HA Khan. Hum. Exp. Toxicol. 2007, 26:687-696.
128. Snyder R., Witz G., Goldstein B.D. The toxicology of benzene. Environ. Health Perspect. 1993, 100:293-306.
129. Sørensen M., Skov H., Autrup H., Hertel O., Loft S. Urban benzene exposure and oxidative DNA damage: influence of genetic polymorphisms in metabolism genes. Sci. Total Environ. 2003, 309:69-80.
130. Sørensen M., Poole J., Autrup H., Muzyka V., Jensen A., Loft S., Knudsen L.E. Benzene exposure assessed by metabolite excretion in Estonian oil shale mineworkers: influence of glutathione s-transferase polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1729-1735.
131. Spatari G., Saitta S., Cimino F., Sapienza D., Quattrocchi P., Carrieri M., et al. Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene. Int. J. Hyg. Environ. Health 2012, 215:389-392.
132. Stillman W.S., Varella-Garcia M., Irons R.D. The benzene metabolite hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19- bone marrow cells. Exp. Hematol. 2000, 28:169-176.
133. Sun P., Qian J., Zhang Z.B., Wan J.X., Wu F., Jin X.P., Fan W.W., Lu D.R., Zhao N.Q., Christiani D.C., Xia Z.L. Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population. Carcinogenesis 2008, 29:2325-2329.
134. Swaen G.M., van Amelsvoort L., Twisk J.J., Verstraeten E., Slootweg R., Collins J.J., Burns C.J. Low level occupational benzene exposure and hematological parameters. Chem. Biol. Interact. 2010, 184:94-100.
135. Testa A., Festa F., Ranaldi R., Giachelia M., Tirindelli D., De Marco A., Owczarek M., Guidotti M., Cozzi R. A multi-biomarker analysis of DNA damage in automobile painters. Environ. Mol. Mutagen 2005, 46:182-188.
136. Thomas R., Hubbard A.E., McHale C.M., Zhang L., Rappaport S.M., Lan Q., Rothman N., Vermeulen R., Guyton K.Z., Jinot J., Sonawane B.R., Smith M.T. Characterization of changes in gene expression and biochemical pathways at low levels of benzene exposure. PLoS One 2014, 9:e91828.
137. Tournel G., Cauffiez C., Billaut-Laden I., Allorge D., Chevalier D., Bonnifet F., Mensier E., Lafitte J.J., Lhermitte M., Broly F., Lo-Guidice J.M. Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant. Mut. Res. 2007, 617:79-89.
138. Tsai S.P., Fox E.E., Ransdell J.D., Wendt J.K., Waddell L.C., Donnelly R.P. A hematology surveillance study of petrochemical workers exposed to benzene. Regul. Toxicol. Pharmacol. 2004, 40:67-73.
139. U.S. Environmental Protection Agency (EPA), 2007. Control of hazardous air pollutants from mobile sources. Fed. Reg. 72, 8428-8476.
140. Valinluck V., Tsai H.H., Rogstad D.K., Burdzy A., Bird A., Sowers L.C. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004, 32:4100-4108.
141. Van Damme K., Casteleyn L. Ethical: social and scientific problems related to the application of genetic screening and genetic monitoring for workers in the context of a European approach to health and safety at work. Med. Lav. 1998, 89:S3-72.
142. Vineis P., Bartsch H., Caporaso N., Harrington A.M., Kadlubar F.F., Landi M.T., Malaveille C., Shields P.G., Skipper P., Talaska G., Tannenbaum S.R. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994, 369(6476 (May)):154-156.
143. Vlaanderen J., Portengen L., Rappaport S.M., Glass D.C., Kromhout H., Vermeulen R. The impact of saturable metabolism on exposure-response relations in 2 studies of benzene-induced leukemia. Am. J. Epidemiol. 2011, 174:621-629.
144. Vlaanderen J., Portengen L., Rothman N., Lan Q., Kromhout H., Vermeulen R. Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ. Health Perspect. 2010, 118:526-532.
145. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., Huang W., Xia Z., Hu G. Association of genetic polymorphisms in CYP2E1 MPO, NQO1GSTM1, and GSTT1 genes with benzene poisoning. Environ. Health Perspect. 2002, 110:1213-1218.
146. Wang L., Zhou Y., Liang Y., Wong O., Armstrong T., Schnatter A.R., Wu Q., Fang J., Ye X., Fu H., Irons R.D. Benzene exposure in the shoemaking industry in China, a literature survey, 1978-2004. Regul. Toxicol. Pharmacol. 2006, 46(2 (November)):149-156.
147. Watanabe J., Hayashi S., Nakachi K., Imai K., Suda Y., Sekine T., Kawajiri K. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acid. Res. 1990, 18:7194.
148. Weisel C.P. Benzene exposure: an overview of monitoring methods and their findings. Chem. Biol. Interact. 2010, 184:58-66.
149. Weisel C.P., Park S., Pyo H., Mohan K., Witz G. Use of stable isotopically labeled benzene to evaluate environmental exposures. J. Expo. Anal. Environ. Epidemiol. 2003, 13:393-402.
150. Whysner J., Reddy M.V., Ross P.M., Mohan M., Lax E.A. Genotoxicity of benzene and its metabolites. Mutat. Res. 2004, 566:99-130.
151. Whitelaw N.C., Whitelaw E. Transgenerational epigenetic inheritance in health and disease. Curr. Opin. Genet. Dev. 2008, 18:273-279.
152. Witz G., Zhang Z., Goldstein B.D. 1996: Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environ. Health Perspect. 1996, 104(Suppl. 6):1195-1199.